|
For the first time, OpenAI is expanding beyond institutional backers and letting individuals buy in.
|
|
Lilly's weight-loss pill wins US approval, sets up next battle with rival Novo Nordisk reuters.comF.D.A. Approves New Weight-Loss Pill The New York TimesFDA approves Eli Lilly's GLP-1 pill, opening the next phase of the weight loss drug market CNBCAnother GLP-1 weight loss pill gets FDA approval, and it has fewer restrictions on how it's used CNN
|
|
The 95-year-old investor said he still comes into the office daily and stays engaged with markets.
|
|
